Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, today announced the commercial launch of the Element AVITI™ System, a benchtop sequencer offering an unrivaled combination of performance, cost, and flexibility. Element’s proprietary Avidity Sequencing™ chemistries enable exceptional accuracy and cost efficiency that is unmatched by other benchtop systems. The AVITI™ System operates […]

Companies Aim to Bring Together LinearDNA™ and Spindle Biotech’s Proprietary Engineered RNA Polymerase to Develop a Next-Generation, Cell-Free mRNA Production Platform STONY BROOK, N.Y. and TORONTO, CANADA – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, and Spindle Biotech Inc. (“Spindle Biotech”), a company focused on the development of […]

Beijing, China –  Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce the formation of two new operationally-focused subsidiaries in China. On September 13, 2021, the Board of Directors of […]

NEW YORK — Opentrons Robotics today announced the largest expansion of its automation portfolio to date, launching four new OT-2 workstation products supporting popular applications, including NGS, PCR and protein purification. These launches build on the success of the OT-2 COVID-19 workstations, which have been used by hundreds of labs around the world to rapidly […]

London, UK – UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), today announces that Nick McCooke, widely recognised leader in the next generation sequencing (NGS) field, has been appointed as Strategic Advisor. Nick was the founding CEO of pioneering NGS company Solexa, which he took from spin-out to its NASDAQ listing in 2005. Solexa was […]

BOSTON, Mass, United States, LAUSANNE, Switzerland, and TAIPEI CITY, Taiwan – SOPHiA GENETICS (Nasdaq: SOPH) today announced that SOFIVA GENOMICS, which is one of the largest genetic testing companies in Taiwan aiming to provide genetic testing to clinicians, is the first institution in Asia Pacific to adopt SOPHiA GENETICS’ technology to support HRD testing. SOFIVA […]

STOCKHOLM — Tataa Biocenter AB, a leading European provider of molecular analysis services with ISO 17025 accreditation, is launching Olink® EXPLORE 3072 proteome profiling service. This new platform offers exceedingly high performance with unprecedented throughput based on Illumina sequencing technology. “Olink® EXPLORE 3072 is the perfect complement to our already optimized genomics and transcriptomics offerings and will be imperative […]

SOUTH SAN FRANCISCO, Calif. and REDWOOD CITY, Calif. – Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Kriya Therapeutics, Inc., a fully integrated company pioneering novel technologies and therapeutics in gene therapy, today announced an antibody discovery agreement for antibodies delivered using […]

LONGMONT, Colorado — ANDE Corporation, the global leader in Rapid DNA, announced the immediate availability of the F7-Chip: the next generation hydrocarbon testing solution. The F7-Chip, developed with support from EnerG-ID Solutions, employs a field-based Rapid DNA Identification method that revolutionizes the analysis of hydrocarbons to detect microbes that cause damage to oil and gas […]

The bioautomation company emerges from stealth mode with investment led by Maverick Ventures and John Stuepelnagel (co-founder of Illumina) CAMBRIDGE, MA – Volta Labs, a bioautomation company developing solutions to streamline the upstream workflows in genomic sequencing, today announced it raised $20 million in a Series A funding round. The round was led by Maverick […]